Related Experiment Videos
New aerosol delivery system for neonatal ventilator circuits
M L Everard1, J Stammers, J G Hardy
1Department of Child Health, Queen's Medical Centre, Nottingham.
Archives of Disease in Childhood
|July 1, 1992
Summary
A new metered dose inhaler (MDI) chamber improves aerosol drug delivery in neonatal ventilators. This system delivers a significant dose to the lower respiratory tract, offering a promising alternative for infant respiratory care.
Area of Science:
- Neonatal Medicine
- Respiratory Therapy
- Pharmaceutical Sciences
Background:
- Aerosolized medications are increasingly beneficial in neonatal intensive care units.
- Traditional jet nebulizers present challenges within mechanical ventilator circuits.
Purpose of the Study:
- To design and evaluate a novel MDI chamber for enhanced aerosol drug delivery in neonatal mechanical ventilation.
- To optimize operating conditions for maximizing drug deposition in the lower airways.
Main Methods:
- An MDI chamber (4 cm x 11 cm) was developed and tested with sodium cromoglycate.
- In vitro studies used a model lung and Draeger Babylog 8000 ventilator to assess drug deposition.
- Ultraviolet spectrophotometry and radiolabeled aerosol studies quantified drug delivery efficiency.
Main Results:
- Optimal drug delivery was achieved by actuating the MDI just before inspiration with the chamber near the endotracheal tube and a one-second inspiratory time.
- 1.5-2% of the dose was deposited on the filter at tidal volumes of 11-22 ml, representing a significantly higher dose per body weight compared to adults.
- Radiolabeled studies confirmed uniform aerosol distribution in rabbit lungs.
Conclusions:
- The developed MDI chamber facilitates significant and reproducible drug delivery to the lower respiratory tract in neonates.
- The system is simple to use and offers a viable alternative to existing aerosol delivery methods for infants.
- This approach holds promise for improving the efficacy of inhaled therapies in critically ill newborns.